160 related articles for article (PubMed ID: 25529320)
1. Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal.
Palmeira-de-Oliveira R; Duarte P; Palmeira-de-Oliveira A; das Neves J; Amaral MH; Breitenfeld L; Martinez-de-Oliveira J
Eur J Contracept Reprod Health Care; 2015; 20(4):259-71. PubMed ID: 25529320
[TBL] [Abstract][Full Text] [Related]
2. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.
Woodsong C; Holt JD
Adv Drug Deliv Rev; 2015 Sep; 92():146-54. PubMed ID: 25703190
[TBL] [Abstract][Full Text] [Related]
4. User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.
Morrow KM; Underhill K; van den Berg JJ; Vargas S; Rosen RK; Katz DF
Arch Sex Behav; 2014 Oct; 43(7):1459-67. PubMed ID: 24452632
[TBL] [Abstract][Full Text] [Related]
5. Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.
Rosen RK; van den Berg JJ; Vargas SE; Senocak N; Shaw JG; Buckheit RW; Smith KA; Guthrie KM
Contraception; 2015 Dec; 92(6):596-601. PubMed ID: 26276246
[TBL] [Abstract][Full Text] [Related]
6. Design aspects of vaginal applicators that influence acceptance among target users.
Bakke AJ; Zaveri T; Higgins MJ; Ziegler GR; Hayes JE
Sci Rep; 2021 May; 11(1):9802. PubMed ID: 33963262
[TBL] [Abstract][Full Text] [Related]
7. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.
Braunstein S; van de Wijgert J
J Womens Health (Larchmt); 2005 Jun; 14(5):424-33. PubMed ID: 15989415
[TBL] [Abstract][Full Text] [Related]
8. Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products.
Hardy E; de Pádua KS; Hebling EM; Osis MJ; Zaneveld LJ
Contraception; 2003 May; 67(5):391-5. PubMed ID: 12742563
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
Beksinska M; Greener R; Smit J; Maphumulo B; Mphili N; Kilbourne-Brook M; Coffey PS
AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
[TBL] [Abstract][Full Text] [Related]
10. Women's perceptions about lubricant use and vaginal wetness during sexual activities.
Jozkowski KN; Herbenick D; Schick V; Reece M; Sanders SA; Fortenberry JD
J Sex Med; 2013 Feb; 10(2):484-92. PubMed ID: 23211029
[TBL] [Abstract][Full Text] [Related]
11. What do portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based survey.
Palmeira-de-Oliveira R; Duarte P; Palmeira-de-Oliveira A; das Neves J; Amaral MH; Breitenfeld L; Martinez-de-Oliveira J
Pharmaceutics; 2014 Oct; 6(4):543-56. PubMed ID: 25337676
[TBL] [Abstract][Full Text] [Related]
12. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
[TBL] [Abstract][Full Text] [Related]
13. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.
Nappi RE; Kokot-Kierepa M
Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244
[TBL] [Abstract][Full Text] [Related]
14. High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.
Mosack KE; Weeks MR; Novick Sylla L; Abbott M
Women Health; 2005; 42(2):71-88. PubMed ID: 16537301
[TBL] [Abstract][Full Text] [Related]
15. Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.
Fan MD; Kramzer LF; Hillier SL; Chang JC; Meyn LA; Rohan LC
Arch Sex Behav; 2017 May; 46(4):1111-1119. PubMed ID: 27571742
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal practices and lactobacilli colonization among women in Accra, Ghana.
McCarthy FN; Nii-Trebi NI; Musah BO; Asmah RH
BMC Womens Health; 2015 Jun; 15():46. PubMed ID: 26040938
[TBL] [Abstract][Full Text] [Related]
17. Chilean women's preferences regarding mode of delivery: which do they prefer and why?
Angeja AC; Washington AE; Vargas JE; Gomez R; Rojas I; Caughey AB
BJOG; 2006 Nov; 113(11):1253-8. PubMed ID: 17014679
[TBL] [Abstract][Full Text] [Related]
18. Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories.
Zaveri T; Powell KA; Guthrie KM; Bakke AJ; Ziegler GR; Hayes JE
BMC Womens Health; 2018 Oct; 18(1):170. PubMed ID: 30342510
[TBL] [Abstract][Full Text] [Related]
19. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
Joanis CL; Hart CW
AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
